UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC Decreases Position in Cardinal Health, Inc. $CAH

Key Points

• UBS Asset Management has decreased its stake in Cardinal Health by 1.1% in Q1, owning approximately 2.3 million shares valued at $316.4 million after selling 25,327 shares.
• Several institutional investors have also adjusted their positions in Cardinal Health, including a 198.3% increase by Jones Financial Companies and new investments from Greykasell Wealth Strategies and NBC Securities.
• Cardinal Health is set to pay a quarterly dividend of $0.5107 per share on October 15, with an annualized yield of 1.4% and a payout ratio of 31.63%.

UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lessened its holdings in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 1.1% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,296,470 shares of the company's stock after selling 25,327 shares during the quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC owned 0.96% of Cardinal Health worth $316,385,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors also recently added to or reduced their stakes in the company. Greykasell Wealth Strategies Inc. purchased a new position in Cardinal Health in the 1st quarter worth $26,000. Jones Financial Companies Lllp raised its position in Cardinal Health by 198.3% in the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company's stock worth $27,000 after purchasing an additional 14,034 shares during the period. Tompkins Financial Corp raised its position in Cardinal Health by 106.7% in the 1st quarter. Tompkins Financial Corp now owns 248 shares of the company's stock worth $34,000 after purchasing an additional 128 shares during the period. GW&K Investment Management LLC raised its position in Cardinal Health by 113.4% in the 1st quarter. GW&K Investment Management LLC now owns 271 shares of the company's stock worth $37,000 after purchasing an additional 144 shares during the period. Finally, NBC Securities Inc. purchased a new position in Cardinal Health in the 1st quarter worth $48,000. Hedge funds and other institutional investors own 87.17% of the company's stock.

Insider Buying and Selling at Cardinal Health

In related news, insider Michelle D. Greene sold 13,500 shares of the business's stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total transaction of $2,009,070.00. Following the sale, the insider owned 14,976 shares of the company's stock, valued at $2,228,728.32. The trade was a 47.41% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO Jason M. Hollar sold 35,901 shares of the business's stock in a transaction dated Wednesday, August 20th. The stock was sold at an average price of $150.04, for a total transaction of $5,386,586.04. Following the sale, the chief executive officer directly owned 200,000 shares in the company, valued at $30,008,000. The trade was a 15.22% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 271,676 shares of company stock valued at $40,489,525 over the last three months. 0.09% of the stock is currently owned by corporate insiders.

Cardinal Health Trading Down 1.0%

Shares of CAH opened at $149.47 on Thursday. The firm's 50-day moving average price is $155.00 and its 200-day moving average price is $147.31. The firm has a market capitalization of $35.69 billion, a price-to-earnings ratio of 23.17, a PEG ratio of 1.28 and a beta of 0.73. Cardinal Health, Inc. has a 1-year low of $106.54 and a 1-year high of $168.44.

Cardinal Health (NYSE:CAH - Get Free Report) last announced its earnings results on Tuesday, August 12th. The company reported $2.08 earnings per share for the quarter, beating analysts' consensus estimates of $2.03 by $0.05. The firm had revenue of $60.16 billion for the quarter, compared to analyst estimates of $60.91 billion. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The company's revenue for the quarter was up .5% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.84 EPS. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. On average, research analysts forecast that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st will be paid a dividend of $0.5107 per share. The ex-dividend date of this dividend is Wednesday, October 1st. This represents a $2.04 annualized dividend and a yield of 1.4%. Cardinal Health's payout ratio is presently 31.63%.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on the stock. Citigroup restated a "neutral" rating and issued a $170.00 price objective (up previously from $157.00) on shares of Cardinal Health in a research report on Friday, June 13th. Bank of America boosted their price objective on shares of Cardinal Health from $165.00 to $170.00 and gave the company a "buy" rating in a research report on Tuesday, June 10th. Leerink Partners decreased their price objective on shares of Cardinal Health from $188.00 to $186.00 and set an "outperform" rating on the stock in a research report on Tuesday, August 12th. Evercore ISI decreased their price objective on shares of Cardinal Health from $200.00 to $190.00 and set an "outperform" rating on the stock in a research report on Wednesday, August 13th. Finally, Robert W. Baird boosted their price objective on shares of Cardinal Health from $197.00 to $203.00 and gave the company an "outperform" rating in a research report on Wednesday, August 13th. Eleven research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $165.93.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.